Global Sucralfate (CAS 54182-58-0) Market Research Report 2016 Industry Growth, Trends, Size, Share and Analysis by 2021
This report provides detailed analysis of worldwide markets for Sucralfate (CAS 54182-58-0) from 2011-2016, and provides extensive market forecasts (2016-2021) by region/country and subsectors. It covers the key technological and market trends in the Sucralfate (CAS 54182-58-0) market and further lays out an analysis of the factors influencing the supply/demand for Sucralfate (CAS 54182-58-0), and the opportunities/challenges faced by industry participants. It also acts as an essential tool to companies active across the value chain and to the new entrants by enabling them to capitalize the opportunities and develop business strategies.
Request For Sample Report: http://www.fiormarkets.com/report-detail/811/request-sample
Sucralfate is a cytoprotective agent, an oral gastrointestinal medication primarily indicated for the treatment of active duodenal ulcers. Brand names include Sucramal in Italy; Carafate in U.S.A.; Sufrate, Sucralcoat, Pepsigard, Sucral, Sucrafil, Hapifate in India; Sutra or Musin in parts of South-East Asia; Sulcrate in Canada; Ulsanic in South Africa and Israel; and Antepsin in Turkey. Sucralfate is also used for the treatment of gastroesophageal reflux disease (GERD) and stress ulcers. Unlike the other classes of medications used for treatment of peptic ulcers, sucralfate is a sucrose sulfate-aluminium complex that binds to the mucosa, thus creating a physical barrier that impairs diffusion of hydrochloric acid in the gastrointestinal tract and prevents degradation of mucus by acid. It also stimulates bicarbonate output and acts like an acid buffer with cytoprotective properties.
GCC’s report, Global Sucralfate (CAS 54182-58-0) Market Outlook 2016-2021, has been prepared based on the synthesis, analysis, and interpretation of information about the global Sucralfate (CAS 54182-58-0) market collected from specialized sources. The report covers key technological developments in the recent times and profiles leading players in the market and analyzes their key strategies. The competitive landscape section of the report provides a clear insight into the market share analysis of key industry players. The major players in the global Sucralfate (CAS 54182-58-0) market areChugai Pharmaceutical, ICL Performance, Euticals, Northeast Pharmaceutical, Haisen Pharmaceutical, Nanjing Pharmaceutical.
The report provides separate comprehensive analytics for the North America, Europe, Asia-Pacific, Middle East and Africa and Rest of World. In this sector, global competitive landscape and supply/demand pattern of Sucralfate (CAS 54182-58-0) industry has been provided.
Table of Content:
Part 1. Scope of Report
1.1 Research Methodology
1.2 Geographic Scope
1.3 Years Considered
Part 2. Introduction
2.1 Key Findings
2.2 Value Chain Analysis
Part 3. Manufacture
3.1 Manufacturing Process
3.2 Issues and Trends
About Fior Markets
Fior Markets is a leading market intelligence company that sells reports of top publishers in the technology industry. Our extensive reseorts cover detailed market assessments that include major technological improvements in the industry. Fior Markets also specializes in analyzing hi-tech systems and current processing systems in its expertise.
Phone: (201) 465-4211